{
    "output": [
        [
            "New Frontier Data",
            "ORG",
            "Impact",
            "Medical Cannabis Sales",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data",
            "ORG",
            "Impact",
            "Adult-Use Sales",
            "ECON_INDICATOR"
        ],
        [
            "California",
            "GPE",
            "Introduce",
            "Recreational Cannabis Laws",
            "EVENT"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Operate_In",
            "Cannabis Industry",
            "SECTOR"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Raise",
            "Significant Amount",
            "ECON_INDICATOR"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Control",
            "State Cannabis Taxes",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data",
            "ORG",
            "Estimate",
            "Medical Sales",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data",
            "ORG",
            "Estimate",
            "Adult-Use Sales",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data",
            "ORG",
            "Project",
            "Legal Cannabis Sales",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data CEO",
            "PERSON",
            "State",
            "Budget Shortfalls",
            "ECON_INDICATOR"
        ],
        [
            "New Frontier Data",
            "ORG",
            "Predict",
            "Revenues",
            "ECON_INDICATOR"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Increase",
            "Private Placement Offering",
            "FIN_INSTRUMENT"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Use",
            "Net Proceeds",
            "ECON_INDICATOR"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Finance",
            "Streaming Partners",
            "COMP"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Pay",
            "General and Administrative Expenses",
            "ECON_INDICATOR"
        ],
        [
            "MMCAP International Inc. SPC",
            "COMP",
            "Subscribe",
            "Convertible Debenture Units",
            "FIN_INSTRUMENT"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "Relate_To",
            "MI 61-101",
            "CONCEPT"
        ],
        [
            "Cannabis Wheaton Income Corp.",
            "COMP",
            "File",
            "Material Change Report",
            "FIN_INSTRUMENT"
        ],
        [
            "Lexaria Bioscience Corp.",
            "COMP",
            "Develop",
            "Delivery Technology",
            "PRODUCT"
        ],
        [
            "Lexaria Bioscience Corp.",
            "COMP",
            "Out-License",
            "Delivery Technology",
            "PRODUCT"
        ],
        [
            "Lexaria Bioscience Corp.",
            "COMP",
            "Announce",
            "New Topical Skin Cream R&D Program",
            "EVENT"
        ],
        [
            "Lexaria Bioscience Corp.",
            "COMP",
            "Formulate",
            "Topical Cream Products",
            "PRODUCT"
        ],
        [
            "Lexaria Bioscience Corp.",
            "COMP",
            "Test",
            "Human Skin Absorption",
            "ECON_INDICATOR"
        ],
        [
            "AXIM Biotechnologies, Inc.",
            "COMP",
            "Focus",
            "Cannabis-Based Pharmaceutical",
            "PRODUCT"
        ],
        [
            "AXIM Biotechnologies, Inc.",
            "COMP",
            "Announce",
            "Clinical Trial Results",
            "EVENT"
        ],
        [
            "AXIM Biotechnologies, Inc.",
            "COMP",
            "Treat",
            "Irritable Bowel Syndrome",
            "CONCEPT"
        ],
        [
            "Corbus Pharmaceuticals Holdings, Inc.",
            "COMP",
            "Initiate",
            "Phase 2 Clinical Study",
            "EVENT"
        ],
        [
            "Corbus Pharmaceuticals Holdings, Inc.",
            "COMP",
            "Develop",
            "Novel Therapeutics",
            "PRODUCT"
        ],
        [
            "Corbus Pharmaceuticals Holdings, Inc.",
            "COMP",
            "Commercialize",
            "Novel Therapeutics",
            "PRODUCT"
        ],
        [
            "Canopy Growth Corporation",
            "COMP",
            "Enter",
            "Distribution Agreement",
            "EVENT"
        ],
        [
            "Canopy Growth Corporation",
            "COMP",
            "Offer",
            "Distinct Brands",
            "PRODUCT"
        ]
    ]
}